Trademark: 97910441
Word
ERVIMMUNE
Status
Pending
Status Code
641
Status Date
Thursday, January 25, 2024
Serial Number
97910441
Mark Type
4000
Filing Date
Thursday, April 27, 2023

Trademark Owner History

Classifications
5 Pharmaceutical preparations for the treatment of cancer; therapeutic vaccines; Medical preparations, namely, T-cell therapy preparations for the treatment of cancer; stem cells for medical use; biological preparations for the prevention and treatment of cancer; chemical preparations for pharmaceutical purposes, namely, for the prevention and treatment of cancer; chemical preparations for medical purposes, namely, for the prevention or treatment of cancer; medicinal preparations for the treatment of infectious diseases and for use in immunotherapy and oncology; all aforementioned goods not for use in the field of medical diagnostics
44 Medical and surgical services in the field of immunotherapy and oncology; medical testing for treatment purposes; provision of medical information in the field of immunotherapy and oncology; medical analysis for the treatment of persons; genetic testing services for medical purposes; all aforementioned services not for use in the field of medical diagnostics
42 Medical research laboratory services; biotechnological and pharmaceutical drug research and development services; pharmaceutical and biotechnological research and development; provision of medical and scientific research information in the field of pharmaceuticals; provision of medical and scientific research information in the field of therapeutic vaccines; provision of medical and scientific research information in the field of oncology, immunotherapy, stem cell therapy, and T-cell therapy; Providing medical and scientific research information in the field of clinical trials; screening and selection of molecules for scientific and pharmacological research purposes, not for medical purposes; research and development in the field of immunotherapy; all aforementioned services not for use in the field of medical diagnostics

Trademark Events
Feb 23, 2024
Teas/Email Correspondence Entered
Feb 22, 2024
Teas Response To Office Action Received
Jan 25, 2024
Notification Of Non-Final Action E-Mailed
Jan 25, 2024
Non-Final Action E-Mailed
Jan 25, 2024
Non-Final Action Written
Jan 24, 2024
Assigned To Examiner
Nov 13, 2023
Preliminary/Voluntary Amendment - Entered
Nov 13, 2023
Assigned To Lie
Jun 8, 2023
Teas Voluntary Amendment Received
May 25, 2023
New Application Office Supplied Data Entered
May 1, 2023
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24